首页> 外文期刊>Oral oncology >Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: Possible mechanisms for immune escape by head and neck cancers.
【24h】

Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: Possible mechanisms for immune escape by head and neck cancers.

机译:口腔癌细胞系可以使用多种配体,包括Fas-L,TRAIL和TNF-α诱导Jurkat T细胞凋亡:头颈癌免疫逃逸的可能机制。

获取原文
获取原文并翻译 | 示例

摘要

Some cancer cells can induce apoptosis in tumour infiltrating cytotoxic T cells as a means of escaping immune destruction. This study examined the expression of the apoptosis-inducing ligands, Fas-L, TRAIL and TNF-alpha, on three representative oral squamous cell carcinoma (OSCC) cell lines, TR146, SCC25 and CAL27 and investigates the contribution of these ligands to tumour cell killing of Jurkat T cells in vitro. All three cell lines were able to induce apoptosis in Jurkat T cells to varying degrees. The TR146 cell line predominantly killed Jurkats via the well known Fas-L/Fas mediated pathway. Although TR146 also expressed low levels of TRAIL and TNF-alpha, these did not contribute significantly to TR146 killing of Jurkats. In contrast, the CAL27 cell line expressed little if any Fas-L but was still able to kill Jurkats effectively via an almost exclusively TRAIL mediated mechanism. The SCC25 cell line expressed significant levels of all three ligands but we were unable to significantly inhibit killing of Jurkats by blocking any one pathway with antibodies. SCC25 may use a combination of mechanisms to kill Jurkats and switch between them to compensate when one mechanism is blocked. We found that stimulation with interferon-gamma (IFN-gamma) induced or increased the expression of apoptosis-inducing ligands on OSCC as well as the killing of Jurkat T cells. Not only did IFN-gamma increase killing of Jurkats, but it changed the contribution of the Fas-L, TRAIL and TNF-alpha mediated mechanisms to the killing of Jurkat T cells by the different cell lines. These mechanisms if reproduced in vivo, could confer survival advantage on OSCC by enabling them to kill tumour invading cytotoxic lymphocytes and evade immune destruction.
机译:一些癌细胞可以诱导浸润肿瘤的细胞毒性T细胞凋亡,这是逃避免疫破坏的一种手段。这项研究检查了凋亡诱导配体Fas-L,TRAIL和TNF-α在三种代表性口腔鳞状细胞癌(OSCC)细胞系TR146,SCC25和CAL27中的表达,并研究了这些配体对肿瘤细胞的贡献在体外杀死Jurkat T细胞。所有三种细胞系均能够不同程度地诱导Jurkat T细胞凋亡。 TR146细胞系主要通过众所周知的Fas-L / Fas介导的途径杀死Jurkats。尽管TR146还表达了低水平的TRAIL和TNF-α,但是它们对TR146杀死Jurkats的贡献不大。相反,CAL27细胞系几乎没有表达Fas-L,但仍然能够通过几乎完全由TRAIL介导的机制有效杀死Jurkats。 SCC25细胞系表达了所有三种配体的显着水平,但我们无法通过用抗体阻断任何一条途径来显着抑制Jurkats的杀伤。 SCC25可以组合使用多种机制来杀死Jurkat,并在其中一种机制被阻止时进行补偿。我们发现用干扰素-γ(IFN-γ)刺激诱导或增加OSCC上凋亡诱导配体的表达以及Jurkat T细胞的杀死。 IFN-γ不仅增加了对Jurkat T细胞的杀灭作用,而且改变了Fas-L,TRAIL和TNF-α介导的机制对不同细胞系对Jurkat T细胞杀灭的贡献。这些机制如果在体内复制,可以使它们杀死侵袭肿瘤的细胞毒性淋巴细胞并逃避免疫破坏,从而赋予OSCC生存优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号